世界のアラジール症候群市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Alagille Syndrome Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5071
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アラジール症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医学、外科学、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アラジール症候群の市場動向
・企業の競争状況、市場シェア
・アラジール症候群の種類別市場規模と予測2016-2027（医学、外科学、その他）
・アラジール症候群の用途別市場規模と予測2016-2027（病院、診療所、その他）
・アラジール症候群の北米市場規模2016-2027（アメリカ、カナダ）
・アラジール症候群の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アラジール症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アラジール症候群の中南米市場規模2016-2027（メキシコ、ブラジル）
・アラジール症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Mirum Pharmaceuticals、Pfizer、Sanofi、Teva Pharmaceutial Industries、Allergen、Lannett、Albireo Pharma、AstraZeneca、Novartis、Shire、Bristol-Myers Squibb、GlaxoSmithKline、Merck、ANI Pharmaceuticals）
・結論

Alagille syndrome is a genetic disorder that can affect the liver, heart, and other parts of the body. One of the major features ofAlagille syndrome is liver damage caused by abnormalities in the bile ducts.

Market Analysis and Insights: Global Alagille Syndrome Market
The global Alagille Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alagille Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alagille Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alagille Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alagille Syndrome market.

Global Alagille Syndrome Scope and Market Size
Alagille Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alagille Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medicine
Surgery
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Mirum Pharmaceuticals
Pfizer
Sanofi
Teva Pharmaceutial Industries
Allergen
Lannett
Albireo Pharma
AstraZeneca
Novartis
Shire
Bristol-Myers Squibb
GlaxoSmithKline
Merck
ANI Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alagille Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Alagille Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alagille Syndrome Market Perspective (2016-2027)
2.2 Alagille Syndrome Growth Trends by Regions
2.2.1 Alagille Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alagille Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Alagille Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Alagille Syndrome Industry Dynamic
2.3.1 Alagille Syndrome Market Trends
2.3.2 Alagille Syndrome Market Drivers
2.3.3 Alagille Syndrome Market Challenges
2.3.4 Alagille Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alagille Syndrome Players by Revenue
3.1.1 Global Top Alagille Syndrome Players by Revenue (2016-2021)
3.1.2 Global Alagille Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Alagille Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alagille Syndrome Revenue
3.4 Global Alagille Syndrome Market Concentration Ratio
3.4.1 Global Alagille Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alagille Syndrome Revenue in 2020
3.5 Alagille Syndrome Key Players Head office and Area Served
3.6 Key Players Alagille Syndrome Product Solution and Service
3.7 Date of Enter into Alagille Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alagille Syndrome Breakdown Data by Type
4.1 Global Alagille Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Alagille Syndrome Forecasted Market Size by Type (2022-2027)

5 Alagille Syndrome Breakdown Data by Application
5.1 Global Alagille Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Alagille Syndrome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alagille Syndrome Market Size (2016-2027)
6.2 North America Alagille Syndrome Market Size by Type
6.2.1 North America Alagille Syndrome Market Size by Type (2016-2021)
6.2.2 North America Alagille Syndrome Market Size by Type (2022-2027)
6.2.3 North America Alagille Syndrome Market Size by Type (2016-2027)
6.3 North America Alagille Syndrome Market Size by Application
6.3.1 North America Alagille Syndrome Market Size by Application (2016-2021)
6.3.2 North America Alagille Syndrome Market Size by Application (2022-2027)
6.3.3 North America Alagille Syndrome Market Size by Application (2016-2027)
6.4 North America Alagille Syndrome Market Size by Country
6.4.1 North America Alagille Syndrome Market Size by Country (2016-2021)
6.4.2 North America Alagille Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Alagille Syndrome Market Size (2016-2027)
7.2 Europe Alagille Syndrome Market Size by Type
7.2.1 Europe Alagille Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Alagille Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Alagille Syndrome Market Size by Type (2016-2027)
7.3 Europe Alagille Syndrome Market Size by Application
7.3.1 Europe Alagille Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Alagille Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Alagille Syndrome Market Size by Application (2016-2027)
7.4 Europe Alagille Syndrome Market Size by Country
7.4.1 Europe Alagille Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Alagille Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alagille Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Alagille Syndrome Market Size by Type
8.2.1 Asia-Pacific Alagille Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alagille Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alagille Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Alagille Syndrome Market Size by Application
8.3.1 Asia-Pacific Alagille Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alagille Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alagille Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Alagille Syndrome Market Size by Region
8.4.1 Asia-Pacific Alagille Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alagille Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alagille Syndrome Market Size (2016-2027)
9.2 Latin America Alagille Syndrome Market Size by Type
9.2.1 Latin America Alagille Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Alagille Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Alagille Syndrome Market Size by Type (2016-2027)
9.3 Latin America Alagille Syndrome Market Size by Application
9.3.1 Latin America Alagille Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Alagille Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Alagille Syndrome Market Size by Application (2016-2027)
9.4 Latin America Alagille Syndrome Market Size by Country
9.4.1 Latin America Alagille Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Alagille Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alagille Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Alagille Syndrome Market Size by Type
10.2.1 Middle East & Africa Alagille Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alagille Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alagille Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Alagille Syndrome Market Size by Application
10.3.1 Middle East & Africa Alagille Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alagille Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alagille Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Alagille Syndrome Market Size by Country
10.4.1 Middle East & Africa Alagille Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alagille Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Mirum Pharmaceuticals
11.1.1 Mirum Pharmaceuticals Company Details
11.1.2 Mirum Pharmaceuticals Business Overview
11.1.3 Mirum Pharmaceuticals Alagille Syndrome Introduction
11.1.4 Mirum Pharmaceuticals Revenue in Alagille Syndrome Business (2016-2021)
11.1.5 Mirum Pharmaceuticals Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Alagille Syndrome Introduction
11.2.4 Pfizer Revenue in Alagille Syndrome Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Alagille Syndrome Introduction
11.3.4 Sanofi Revenue in Alagille Syndrome Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Teva Pharmaceutial Industries
11.4.1 Teva Pharmaceutial Industries Company Details
11.4.2 Teva Pharmaceutial Industries Business Overview
11.4.3 Teva Pharmaceutial Industries Alagille Syndrome Introduction
11.4.4 Teva Pharmaceutial Industries Revenue in Alagille Syndrome Business (2016-2021)
11.4.5 Teva Pharmaceutial Industries Recent Development
11.5 Allergen
11.5.1 Allergen Company Details
11.5.2 Allergen Business Overview
11.5.3 Allergen Alagille Syndrome Introduction
11.5.4 Allergen Revenue in Alagille Syndrome Business (2016-2021)
11.5.5 Allergen Recent Development
11.6 Lannett
11.6.1 Lannett Company Details
11.6.2 Lannett Business Overview
11.6.3 Lannett Alagille Syndrome Introduction
11.6.4 Lannett Revenue in Alagille Syndrome Business (2016-2021)
11.6.5 Lannett Recent Development
11.7 Albireo Pharma
11.7.1 Albireo Pharma Company Details
11.7.2 Albireo Pharma Business Overview
11.7.3 Albireo Pharma Alagille Syndrome Introduction
11.7.4 Albireo Pharma Revenue in Alagille Syndrome Business (2016-2021)
11.7.5 Albireo Pharma Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Alagille Syndrome Introduction
11.8.4 AstraZeneca Revenue in Alagille Syndrome Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Alagille Syndrome Introduction
11.9.4 Novartis Revenue in Alagille Syndrome Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Shire
11.10.1 Shire Company Details
11.10.2 Shire Business Overview
11.10.3 Shire Alagille Syndrome Introduction
11.10.4 Shire Revenue in Alagille Syndrome Business (2016-2021)
11.10.5 Shire Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Alagille Syndrome Introduction
11.11.4 Bristol-Myers Squibb Revenue in Alagille Syndrome Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Alagille Syndrome Introduction
11.12.4 GlaxoSmithKline Revenue in Alagille Syndrome Business (2016-2021)
11.12.5 GlaxoSmithKline Recent Development
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Alagille Syndrome Introduction
11.13.4 Merck Revenue in Alagille Syndrome Business (2016-2021)
11.13.5 Merck Recent Development
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Company Details
11.14.2 ANI Pharmaceuticals Business Overview
11.14.3 ANI Pharmaceuticals Alagille Syndrome Introduction
11.14.4 ANI Pharmaceuticals Revenue in Alagille Syndrome Business (2016-2021)
11.14.5 ANI Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alagille Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Alagille Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Alagille Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Alagille Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Alagille Syndrome Market Share by Regions (2016-2021)
Table 9. Global Alagille Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Alagille Syndrome Market Share by Regions (2022-2027)
Table 11. Alagille Syndrome Market Trends
Table 12. Alagille Syndrome Market Drivers
Table 13. Alagille Syndrome Market Challenges
Table 14. Alagille Syndrome Market Restraints
Table 15. Global Alagille Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Alagille Syndrome Market Share by Players (2016-2021)
Table 17. Global Top Alagille Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alagille Syndrome as of 2020)
Table 18. Ranking of Global Top Alagille Syndrome Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Alagille Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alagille Syndrome Product Solution and Service
Table 22. Date of Enter into Alagille Syndrome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alagille Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Alagille Syndrome Revenue Market Share by Type (2016-2021)
Table 26. Global Alagille Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Alagille Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Alagille Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Alagille Syndrome Revenue Market Share by Application (2016-2021)
Table 30. Global Alagille Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Alagille Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Alagille Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Alagille Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Alagille Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Alagille Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Alagille Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Alagille Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Alagille Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Alagille Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Alagille Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Alagille Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Alagille Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Alagille Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Alagille Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Alagille Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Alagille Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Alagille Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Alagille Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Alagille Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Alagille Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Alagille Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Alagille Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Alagille Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Alagille Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Alagille Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Alagille Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Alagille Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Alagille Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Alagille Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Alagille Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Alagille Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 62. Mirum Pharmaceuticals Company Details
Table 63. Mirum Pharmaceuticals Business Overview
Table 64. Mirum Pharmaceuticals Alagille Syndrome Product
Table 65. Mirum Pharmaceuticals Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 66. Mirum Pharmaceuticals Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Alagille Syndrome Product
Table 70. Pfizer Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Alagille Syndrome Product
Table 75. Sanofi Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Teva Pharmaceutial Industries Company Details
Table 78. Teva Pharmaceutial Industries Business Overview
Table 79. Teva Pharmaceutial Industries Alagille Syndrome Product
Table 80. Teva Pharmaceutial Industries Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutial Industries Recent Development
Table 82. Allergen Company Details
Table 83. Allergen Business Overview
Table 84. Allergen Alagille Syndrome Product
Table 85. Allergen Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 86. Allergen Recent Development
Table 87. Lannett Company Details
Table 88. Lannett Business Overview
Table 89. Lannett Alagille Syndrome Product
Table 90. Lannett Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 91. Lannett Recent Development
Table 92. Albireo Pharma Company Details
Table 93. Albireo Pharma Business Overview
Table 94. Albireo Pharma Alagille Syndrome Product
Table 95. Albireo Pharma Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 96. Albireo Pharma Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Alagille Syndrome Product
Table 104. Novartis Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 105. Novartis Recent Development
Table 106. Shire Company Details
Table 107. Shire Business Overview
Table 108. Shire Alagille Syndrome Product
Table 109. Shire Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 110. Shire Recent Development
Table 111. Bristol-Myers Squibb Company Details
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Alagille Syndrome Product
Table 114. Bristol-Myers Squibb Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 115. Bristol-Myers Squibb Recent Development
Table 116. GlaxoSmithKline Company Details
Table 117. GlaxoSmithKline Business Overview
Table 118. GlaxoSmithKline Alagille Syndrome Product
Table 119. GlaxoSmithKline Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 120. GlaxoSmithKline Recent Development
Table 121. Merck Company Details
Table 122. Merck Business Overview
Table 123. Merck Alagille Syndrome Product
Table 124. Merck Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 125. Merck Recent Development
Table 126. ANI Pharmaceuticals Company Details
Table 127. ANI Pharmaceuticals Business Overview
Table 128. ANI Pharmaceuticals Alagille Syndrome Product
Table 129. ANI Pharmaceuticals Revenue in Alagille Syndrome Business (2016-2021) & (US$ Million)
Table 130. ANI Pharmaceuticals Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alagille Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Alagille Syndrome Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Alagille Syndrome Report Years Considered
Figure 10. Global Alagille Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Alagille Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Alagille Syndrome Market Share by Regions: 2020 VS 2027
Figure 13. Global Alagille Syndrome Market Share by Regions (2022-2027)
Figure 14. Global Alagille Syndrome Market Share by Players in 2020
Figure 15. Global Top Alagille Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alagille Syndrome as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Alagille Syndrome Revenue in 2020
Figure 17. Global Alagille Syndrome Revenue Market Share by Type (2016-2021)
Figure 18. Global Alagille Syndrome Revenue Market Share by Type (2022-2027)
Figure 19. North America Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Alagille Syndrome Market Share by Type (2016-2027)
Figure 21. North America Alagille Syndrome Market Share by Application (2016-2027)
Figure 22. North America Alagille Syndrome Market Share by Country (2016-2027)
Figure 23. United States Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Alagille Syndrome Market Share by Type (2016-2027)
Figure 27. Europe Alagille Syndrome Market Share by Application (2016-2027)
Figure 28. Europe Alagille Syndrome Market Share by Country (2016-2027)
Figure 29. Germany Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Alagille Syndrome Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Alagille Syndrome Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Alagille Syndrome Market Share by Region (2016-2027)
Figure 39. China Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Alagille Syndrome Market Share by Type (2016-2027)
Figure 47. Latin America Alagille Syndrome Market Share by Application (2016-2027)
Figure 48. Latin America Alagille Syndrome Market Share by Country (2016-2027)
Figure 49. Mexico Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Alagille Syndrome Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Alagille Syndrome Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Alagille Syndrome Market Share by Country (2016-2027)
Figure 55. Turkey Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Alagille Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Mirum Pharmaceuticals Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 61. Teva Pharmaceutial Industries Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 62. Allergen Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 63. Lannett Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 64. Albireo Pharma Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 67. Shire Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 70. Merck Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 71. ANI Pharmaceuticals Revenue Growth Rate in Alagille Syndrome Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年）

Global Usher Syndrome Threapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5003 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アッシャー症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NT-501、QRX-411、QRX-421、SAR-421869、その他）、用途別市場規模（クリニック、病院、その他）、主要地域...

世界のブルガダ症候群市場規模・現状・予測（2021年-2027年）

Global Brugada Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5638 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ブルガダ症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（大人、子供）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米...

世界のウェスト症候群市場規模・現状・予測（2021年-2027年）

Global West Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5039 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ウェスト症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Myelodysplastic Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-4519 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、骨髄異形成症候群分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年）

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6000 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、過敏性腸症候群（IBS）処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IBS-D薬、IBS-C薬、その他）、用途別市場規模（女性用、男性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の閉塞性細気管支炎症候群市場規模・現状・予測（2021年-2027年）

Global Bronchiolitis Obliterans Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-3944 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、閉塞性細気管支炎症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（吸入式、経口式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年）

Global Dumping Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4163 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ダンピング症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Usher Syndrome Threapeutics Market The global Usher Syndrome Threapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界のウェスト症候群市場規模・現状・予測（2021年-2027年） West syndrome is an age-related specific epileptic encephalopathy due to multiple and diverse causes. It is characterized by a unique type of seizure called epileptic (infantile) spasms and gross EEG abnormalities of hypsarrhythmia. Usually, West syndrome consists of a characteristic triad: infantil…
世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
世界の閉塞性細気管支炎症候群市場規模・現状・予測（2021年-2027年） Bronchiolitis obliterans may result from lung injury caused by a variety of different chemicals and respiratory infections. Inhaled chemicals known to irritate the lungs and lead to the condition include chlorine; ammonia; oxides of nitrogen or sulfur dioxide; welding fumes; or food flavoring fumes …
世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年） A diagnostic method for myelodysplastic syndrome Market Analysis and Insights: Global Molecular Diagnosis of Myelodysplastic Syndrome Market The global Molecular Diagnosis of Myelodysplastic Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of …